Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

Diego, Daniela S.; Kammler, Roswitha; Demeestere, Isabelle; Niman, Samuel; Partridge, Ann; Ruggeri, Monica; Saura Manich, Cristina

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Diego, Daniela S.
dc.contributor.author	Kammler, Roswitha
dc.contributor.author	Demeestere, Isabelle
dc.contributor.author	Niman, Samuel
dc.contributor.author	Partridge, Ann
dc.contributor.author	Ruggeri, Monica
dc.contributor.author	Saura Manich, Cristina
dc.date.accessioned	2025-11-24T13:38:43Z
dc.date.available	2025-11-24T13:38:43Z
dc.date.issued	2025-12
dc.identifier.citation	Demeestere I, Niman SM, Partridge AH, Diego DS, Kammler R, Ruggeri M, et al. Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]. The Breast. 2025 Dec;84:104570.
dc.identifier.issn	0960-9776
dc.identifier.uri	http://hdl.handle.net/11351/14094
dc.description	Tecnologia de reproducció assistida; Càncer de mama; Reserva ovàrica
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	The Breast;84
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Embaràs
dc.subject	Fecundació
dc.subject	Mama - Càncer
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	Fertility Preservation
dc.subject.mesh	Pregnancy
dc.title	Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.breast.2025.104570
dc.subject.decs	neoplasias de la mama
dc.subject.decs	conservación de la fertilidad
dc.subject.decs	embarazo
dc.relation.publishversion	https://doi.org/10.1016/j.breast.2025.104570
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Demeestere I] Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium. Gynecology and Obstetrics Department, Fertility Clinic, H.U.B Erasme Hospital, Brussels, Belgium. [Niman SM] International Breast Cancer Study Group Statistical Center, Boston, MA, USA. Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA. [Partridge AH] Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. [Diego DS] Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, USA. [Kammler R] Translational Research Coordination, International Breast Cancer Study Group, a division of ETOP IBCSG Partners Foundation, Bern, Switzerland. [Ruggeri M] Program for Young Patients, International Breast Cancer Study Group, a division of ETOP IBCSG Partners Foundation, Bern, Switzerland. [Saura C] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain
dc.identifier.pmid	40987054
dc.rights.accessrights	info:eu-repo/semantics/openAccess